Protagenic Therapeutics (PTIX) News Today → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free PTIX Stock Alerts $1.38 -0.18 (-11.50%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineProtagenic Therapeutics (PTIX) vs. Its Peers Head-To-Head Surveyamericanbankingnews.com - April 18 at 1:14 AMProtagenic Therapeutics, Inc.: Protagenic Therapeutics' Innovative Peptide PT00114 to be Highlighted at Boston Summitfinanznachrichten.de - April 17 at 10:34 AMProtagenic Therapeutics’ Innovative Peptide PT00114 to be Highlighted at Boston Summitfinance.yahoo.com - April 17 at 10:34 AMProtagenic Therapeutics, Inc. (NASDAQ:PTIX) Q4 2023 Earnings Call Transcriptmsn.com - April 2 at 5:10 PMProtagenic Therapeutics Successfully Concludes Third Cohort in Single Dose Portion of Phase 1 Trial for Stress-Related Neuropsychiatric Disordersfinance.yahoo.com - March 27 at 9:11 AMProtagenic Therapeutics, Inc.: Protagenic Therapeutics Schedules First Q4 and FY 2023 Earnings Callfinanznachrichten.de - March 25 at 10:20 PMProtagenic Therapeutics Achieves First Clinical Safety Milestone with its Novel Neuropeptide for the Potential Treatment of Stress-Related Disordersfinance.yahoo.com - February 13 at 9:51 AMmarketbeat.com - January 4 at 2:44 PMProtagenic Therapeutics Inc PTIXmorningstar.com - December 17 at 10:34 PMPTIX Protagenic Therapeutics, Inc.seekingalpha.com - November 14 at 11:32 PMProtagenic Therapeutics, Inc.: Protagenic Therapeutics Announces Date of Annual Shareholder Meetingfinanznachrichten.de - October 13 at 10:18 AMProtagenic Therapeutics Announces Date of Annual Shareholder Meetingfinance.yahoo.com - October 13 at 10:18 AMProtagenic Therapeutics, Inc.: Protagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114finanznachrichten.de - September 26 at 10:16 AMProtagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114finance.yahoo.com - September 26 at 10:16 AMPTIX - Protagenic Therapeutics, Inc.uk.finance.yahoo.com - June 17 at 2:21 PMProtagenic Therapeutics Stock (NASDAQ:PTIX), Dividendsbenzinga.com - March 24 at 7:36 AMProtagenic Therapeutics, Inc.: Protagenic Therapeutics to Effect 1-for-4 Reverse Stock Splitfinanznachrichten.de - March 22 at 6:04 PMProtagenic Therapeutics to Effect 1-for-4 Reverse Stock Splitfinance.yahoo.com - March 22 at 6:04 PMPTIX_old Historical Datainvesting.com - September 7 at 11:05 PMProtagenic Therapeutics, Inc. (PTIX)finance.yahoo.com - August 12 at 10:04 PMProtagenic Therapeutics to Present at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference on April 27thfinance.yahoo.com - April 26 at 9:56 AMProtagenic Therapeutics, Inc. Common Stock (PTIX)nasdaq.com - January 20 at 11:08 PMProtagenic Therapeutics Announces Third Quarter 2021 Results and Business Updatefinance.yahoo.com - November 16 at 12:19 PMProtagenic Therapeutics to Host Virtual Science Review Wednesday, September 8th at 10 AM ETfinance.yahoo.com - August 30 at 9:43 AMProtagenic Therapeutics Announces Second Quarter 2021 Results and Provides Business Updatefinance.yahoo.com - August 17 at 6:08 PMProtagenic Therapeutics Updates on Patient Enrollment for PT00114 Trial, Shares Lowermarketwatch.com - July 23 at 7:33 PMProtagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 ...apnews.com - July 23 at 7:33 PMProtagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 Clinical Trialfinance.yahoo.com - July 23 at 7:33 PM Get Protagenic Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PTIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Urgent Nvidia Warning (Ad)Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space. Click here to access… PTIX Media Mentions By Week PTIX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PTIX News Sentiment▼0.000.32▲Average Medical News Sentiment PTIX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PTIX Articles This Week▼00▲PTIX Articles Average Week Get Protagenic Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PTIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Tenax Therapeutics News Adial Pharmaceuticals News Clever Leaves News Trevena News Cadrenal Therapeutics News Can-Fite BioPharma News eFFECTOR Therapeutics News Kineta News Pasithea Therapeutics News Enveric Biosciences News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PTIX) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressWhy Big Pharma is Investing Billions in This BiotechBehind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protagenic Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
